< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Responsible
From17 Dec 2020 → Today - Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
1 - 10 of 50
- Collaborative licensing models for marine genetic resources in striving for efficient, accessible and equitable management of intellectual property rightsFrom12 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to create sustainable market access to advanced therapies?From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Organoid technologies for disease modeling, drug discovery and development for rare diseasesFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and EffectivenessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Does patient empowerment foster access to and re-use of data in biomedical research, while allowing for meaningful protection of the fundamental right to data protection of patients?From1 Nov 2023 → TodayFunding: FWO junior postdoctoral fellowship
- What are the key factors needed for potential valorization of Marine Natural Products (MNPs)?From1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder Perspectives on Gene Therapy in CardiomyopathyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom11 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Shared decision-making for lung cancer prevention: patient-driven development and evaluation of a decision aid for patients and healthcare providersFrom1 Sep 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Patient Experience Data for Innovative TherapiesFrom31 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
91 - 100 of 213
- The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review(2020)
Authors: Liese Barbier, Paul Declerck, Steven Simoens, Arnold Vulto, Isabelle Huys
Pages: 734 - 755 - ReDIReCT - Repurposing of Drugs: Innovative Revision of Cancer Treatment(2020)
Authors: Ciska Verbaanderd, Isabelle Huys
- Unlocking Marine Genetic Resources: Streamlining the Legal, Policy and Business Aspects of the Marine Biodiscovery Pipeline(2020)
Authors: Jane Collins, Isabelle Huys
- A multifaceted view on market access of biosimilars(2020)
Authors: Evelien Moorkens, Isabelle Huys, Paul Declerck, Arnold Vulto
- Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages(2020)
Authors: Isabelle Huys
- Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions(2020)
Authors: Laurenz Govaerts, Walter Van Dyck, Steven Simoens, Isabelle Huys
Pages: 410 - 417 - Biosimilars in Belgium: a proposal for a more competitive market(2020)
Authors: Evelien Moorkens, Arnold Vulto, Isabelle Huys
Pages: 1 - 12 - Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals(2020)
Authors: Eline van Overbeeke, Thomas De Rijdt, Isabelle Huys
- Stakeholder Perspectives on Access and Benefit-Sharing for Areas Beyond National Jurisdiction(2020)
Authors: Jane Collins, Isabelle Huys
- Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries(2020)
Authors: Laurenz Govaerts, Steven Simoens, Walter Van Dyck, Isabelle Huys
Pages: 606 - 615